The Inovio Pharmaceuticals recently announced that a second patient with human papillomavirus (HPV) head and neck cancer has achieved sustained complete remission in the first phase of the trial after INO-3112 (nowRead More…
Sanofi and Merck’s Hexavalent Combination Vaccine Approved for the Prevention of Multiple Diseases in Pediatrics
Sanofi has announced that the FDA has approved Vaxelis, a full-liquid ready-to-use hexavalent combination vaccine for infants from 6 weeks old to 4 years old (before the 5th birthday). The vaccine isRead More…
Major Breakthrough in HIV Vaccine Research
In a recent study published in Science Advances, scientists from the Scripps Research Institute overcame technical hurdles to develop a new HIV vaccine candidate that stimulates the body to produce a powerfulRead More…
Sanofi Dengvaxia Awarded US FDA Priority Review as the World’s First Dengue Vaccine
Sanofi, a French pharmaceutical giant, recently announced that the US Food and Drug Administration (FDA) has accepted the dengue vaccine Dengvaxia’s Biologics License Application (BLA) and granted priority review. The vaccine isRead More…